Introduksjon
Denne siden gir en grundig analyse av den kjente historikken for insidernes handelsaktiviteter for Henry J Fuchs. Insidere er ledere, direktører eller betydelige investorer i et selskap. Det er ulovlig for insidere å gjøre handler i deres selskaper basert på spesifikke, ikke-offentlig informasjon. Dette betyr ikke at det er ulovlig for dem å gjøre noen handler i deres egne selskaper. Imidlertid må de rapportere alle handler til SEC via et skjema 4. Til tross for disse begrensningene, antyder akademisk forskning at insidere - generelt sett - har en tendens til å overgå markedet i sine egne selskaper.
Gjennomsnittlig handelslønnsomhet
Den gjennomsnittlige handelslønnsomheten er den gjennomsnittlige avkastningen av alle åpne markedskjøp gjort av insideren de siste tre årene. For å beregne dette, undersøker vi hvert eneste åpne marked, uplanlagte kjøp som er gjort av insideren, men dette inkluderer ikke alle handler som ble markert som en del av en 10b5-1 handelsplan. Vi beregner deretter gjennomsnittlig ytelse av disse handlene over 3, 6 og 12 måneder, gjennomsnittlig hver av disse varighetene for å generere en endelig ytelsesmåling for hver handel. Til slutt,
Dersom lønnsomheten for denne interne handelen er "N/A", har enten den interne personen ikke gjort noen åpen-markeds kjøp de siste tre årene, eller så er handlene for nylig til å beregne en pålitelig prestasjonsmåler.
Oppdateringsfrekvens: Daglig
Selskaper med rapporterte insiderposisjoner
SEC-arkiveringene indikerer at Henry J Fuchs har rapporterte beholdninger av handler i følgende selskaper:
Verdipapir | Navn | Siste rapporterte høydepunkter |
---|---|---|
US:BMRN / BioMarin Pharmaceutical Inc. | President, Worldwide R&D | 185 074 |
US:MRTX / Mirati Therapeutics, Inc. | Director | 10 465 |
US:GHDX / Genomic Health, Inc. | Director | 0 |
US:RDEA / Ardea Biosciences, Inc. | Director | 0 |
Hvordan tolke diagrammene
De følgende diagrammene viser aksjens ytelse etter hver åpen markedstransaksjon som ikke var planlagt, utført av Henry J Fuchs. Ikke-planlagte handler er handler som ikke ble gjort som en del av en 10b5-1 handelsplan. Aksjeytelsen er kartlagt som kumulativ prosentendring i aksjekursen. For eksempel, hvis en innsidehandel ble gjort 1. januar 2019, vil diagrammet vise daglig prosentendring for verdipapiret til dagens dato. Dersom aksjeprisen går fra $10 til $15 i løpet av denne tiden, vil den kumulative prosentendringen i aksjeprisen være 50%. En endring i prisen fra $10 til $20 vil være 100%, og en endring i prisen fra $10 til $5 vil være - 50%.
Til syvende og sist er målet vårt å avgjøre hvor tett insidernes handler korrelerer med overavkastninger (positiv eller negativ) i aksjekursen for å se om insidere timer sine handler for å tjene på intern informasjon. Se for deg en situasjon der en insider gjør dette. I denne situasjonen, forventer vi enten (a) positive avkastninger etter kjøp, eller (b) negative avkastninger etter salg. I tilfelle (a) KJØP-diagrammet ville vise en serie av oppadgående kurver, som indikerer positive avkastninger etter hver kjøpstransaksjon. I tilfelle (b) ville SALG-diagrammet vise en serie av nedadgående kurver, som indikerer negative avkastninger etter hver salgstransaksjon.
Imidlertid er dette alene ikke nok til å dra konklusjoner. Hvis, for eksempel, aksjeprisen for selskapet steg jevnt over mange år uten å følge en syklisk trend, ville vi forventet at alle postkjøpsdiagrammer skal ha en stigende trend. På samme måte vil ikke-sykliske nedganger over mange år resultere i nedadgående trend i post-trade diagrammer. Ingen av disse diagrammene ville antyde aktiviteter som insidertrening.
Den sterkeste indikatoren ville vært en situasjon der aksjekursen var ekstremt syklisk, og det var både positive signaler i KJØPSdiagrammet og negative plot i SALGSdiagrammet. Denne situasjonen ville vært sterkt antydende om en insider som timet handler til sin økonomiske fordel.
Innsidernes handelshistorikk
Tabellen viser den komplette listen over innsidehandler gjort av Henry J Fuchs som avslørt til Securies Exchange Comission (SEC).
Fildato | Transaksjonsdato | Skjema | Ticker | Verdipapir | Kode | Aksjer | Gjenværende aksjer | Prosent endring |
Aksje pris |
Transaksjons verdi |
Gjenværende verdi |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-09-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −12 098 | 185 074 | −6,14 | 84,90 | −1 027 120 | 15 712 783 | |
2024-09-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 300 | 197 172 | 0,15 | 68,65 | 20 594 | 13 535 069 | |
2024-03-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −33 485 | 196 872 | −14,54 | 83,87 | −2 808 387 | 16 511 655 | |
2024-03-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 18 240 | 230 357 | 8,60 | ||||
2024-03-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −35 341 | 212 117 | −14,28 | 85,18 | −3 010 396 | 18 068 423 | |
2024-02-29 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 9 238 | 247 458 | 3,88 | ||||
2024-02-29 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 13 326 | 238 220 | 5,93 | ||||
2024-02-29 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 30 640 | 224 894 | 15,77 | ||||
2023-12-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 17 750 | 194 254 | 10,06 | ||||
2023-12-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 317 | 176 504 | 0,18 | 66,88 | 21 200 | 11 804 235 | |
2023-08-11 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −12 000 | 176 187 | −6,38 | 90,43 | −1 085 111 | 15 931 868 | |
2023-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −36 000 | 188 187 | −16,06 | 93,41 | −3 362 760 | 17 578 548 | |
2023-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −4 799 | 224 187 | −2,10 | 87,74 | −421 064 | 19 670 167 | |
2023-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 16 840 | 228 986 | 7,94 | ||||
2023-03-02 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 13 392 | 212 146 | 6,74 | ||||
2023-03-02 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 18 220 | 198 754 | 10,09 | ||||
2023-03-02 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 36 440 | 180 534 | 25,29 | ||||
2023-02-10 |
|
5 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 341 | 144 094 | 0,24 | 62,41 | 21 281 | 8 992 474 | |
2023-01-24 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
A - Award | 4 444 | 10 465 | 73,81 | ||||
2022-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −2 259 | 143 753 | −1,55 | 80,72 | −182 346 | 11 603 742 | |
2022-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
A - Award | 35 830 | 35 830 | |||||
2022-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −12 101 | 146 012 | −7,65 | 78,27 | −947 145 | 11 428 359 | |
2022-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 38 790 | 158 113 | 32,51 | ||||
2022-03-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 12 840 | 119 323 | 12,06 | ||||
2022-02-14 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Non Qualified Stock Option (right to buy) |
M - Exercise | X | −5 000 | 0 | −100,00 | |||
2022-02-14 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Non Qualified Stock Option (right to buy) |
M - Exercise | X | −6 000 | 0 | −100,00 | |||
2022-02-14 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | X | −210 | 6 021 | −3,37 | 106,34 | −22 332 | 640 277 |
2022-02-14 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | X | −8 700 | 6 231 | −58,27 | 105,80 | −920 428 | 659 217 |
2022-02-14 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | X | −2 090 | 14 931 | −12,28 | 104,76 | −218 958 | 1 564 240 |
2022-02-14 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
M - Exercise | X | 5 000 | 17 021 | 41,59 | 20,54 | 102 700 | 349 611 |
2022-02-14 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
M - Exercise | X | 6 000 | 12 021 | 99,65 | 20,54 | 123 240 | 246 911 |
2022-02-11 |
|
5 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 341 | 106 483 | 0,32 | 62,41 | 21 281 | 6 645 285 | |
2022-01-18 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Non Qualified Stock Option (right to buy) |
A - Award | 3 688 | 3 688 | |||||
2022-01-18 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
A - Award | 2 546 | 6 021 | 73,27 | ||||
2021-03-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −2 454 | 106 142 | −2,26 | 78,52 | −192 688 | 8 334 270 | |
2021-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −2 259 | 108 596 | −2,04 | 77,21 | −174 417 | 8 384 697 | |
2021-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
A - Award | 37 710 | 37 710 | |||||
2021-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −7 460 | 110 855 | −6,31 | 78,39 | −584 789 | 8 689 923 | |
2021-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 15 320 | 118 315 | 14,87 | ||||
2021-01-20 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Non Qualified Stock Option (right to buy) |
A - Award | 2 155 | 2 155 | |||||
2021-01-20 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
A - Award | 1 475 | 3 475 | 73,75 | ||||
2020-12-16 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Non Qualified Stock Option (right to buy) |
M - Exercise | X | −10 000 | 6 000 | −62,50 | |||
2020-12-16 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | X | −40 | 2 000 | −1,96 | 237,90 | −9 516 | 475 800 |
2020-12-16 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | X | −451 | 2 040 | −18,11 | 237,36 | −107 049 | 484 212 |
2020-12-16 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | X | −1 821 | 2 491 | −42,23 | 235,19 | −428 284 | 585 862 |
2020-12-16 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | X | −610 | 4 312 | −12,39 | 234,27 | −142 907 | 1 010 188 |
2020-12-16 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | X | −4 461 | 4 922 | −47,54 | 233,40 | −1 041 207 | 1 148 806 |
2020-12-16 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | X | −1 399 | 9 383 | −12,98 | 232,01 | −324 576 | 2 176 909 |
2020-12-16 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | X | −1 218 | 10 782 | −10,15 | 230,19 | −280 368 | 2 481 882 |
2020-12-16 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
M - Exercise | X | 10 000 | 12 000 | 500,00 | 20,54 | 205 400 | 246 480 |
2020-08-11 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Non Qualified Stock Option (right to buy) |
M - Exercise | X | −10 000 | 5 000 | −66,67 | |||
2020-08-11 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | X | −500 | 2 000 | −20,00 | 133,07 | −66 536 | 266 144 |
2020-08-11 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | X | −5 800 | 2 500 | −69,88 | 132,34 | −767 568 | 330 848 |
2020-08-11 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | X | −1 300 | 8 300 | −13,54 | 131,08 | −170 408 | 1 087 986 |
2020-08-11 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | X | −1 000 | 9 600 | −9,43 | 129,80 | −129 803 | 1 246 109 |
2020-08-11 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | X | −900 | 10 600 | −7,83 | 128,56 | −115 707 | 1 362 771 |
2020-08-11 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | X | −500 | 11 500 | −4,17 | 127,52 | −63 762 | 1 466 526 |
2020-08-11 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
M - Exercise | X | 10 000 | 12 000 | 500,00 | 20,54 | 205 400 | 246 480 |
2020-07-22 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
M - Exercise | X | −49 423 | 0 | −100,00 | |||
2020-07-22 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
M - Exercise | X | −75 716 | 0 | −100,00 | |||
2020-07-22 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
M - Exercise | X | −1 250 | 0 | −100,00 | |||
2020-07-22 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −126 389 | 102 995 | −55,10 | 130,00 | −16 430 570 | 13 389 350 |
2020-07-22 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 49 423 | 229 384 | 27,46 | 63,10 | 3 118 591 | 14 474 130 |
2020-07-22 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 75 716 | 179 961 | 72,63 | 67,81 | 5 134 302 | 12 203 155 |
2020-07-22 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 1 250 | 104 245 | 1,21 | 67,81 | 84 762 | 7 068 853 |
2020-07-15 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
M - Exercise | X | −8 977 | 49 423 | −15,37 | |||
2020-07-15 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
M - Exercise | X | −13 810 | 75 716 | −15,43 | |||
2020-07-15 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
M - Exercise | X | −224 | 1 250 | −15,20 | |||
2020-07-15 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −23 011 | 102 995 | −18,26 | 130,00 | −2 991 430 | 13 389 350 |
2020-07-15 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 8 977 | 126 006 | 7,67 | 63,10 | 566 449 | 7 950 979 |
2020-07-15 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 13 810 | 117 029 | 13,38 | 67,81 | 936 456 | 7 935 736 |
2020-07-15 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 224 | 103 219 | 0,22 | 67,81 | 15 189 | 6 999 280 |
2020-07-15 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 339 | 102 995 | 0,33 | 62,59 | 21 217 | 6 446 045 | |
2020-04-28 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 680 | 102 656 | −2,54 | 97,32 | −260 813 | 9 990 318 |
2020-04-28 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −3 678 | 105 336 | −3,37 | 96,85 | −356 211 | 10 201 707 |
2020-04-28 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −13 642 | 109 014 | −11,12 | 95,34 | −1 300 593 | 10 393 111 |
2020-04-22 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −17 213 | 122 656 | −12,31 | 90,00 | −1 549 170 | 11 039 040 |
2020-03-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −5 836 | 139 869 | −4,01 | 73,05 | −426 320 | 10 217 430 | |
2020-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
A - Award | 51 970 | 51 970 | |||||
2020-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 18 220 | 145 705 | 14,29 | ||||
2020-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −10 496 | 127 485 | −7,61 | 84,50 | −886 912 | 10 772 482 | |
2020-03-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 13 136 | 137 981 | 10,52 | ||||
2020-01-07 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Non Qualified Stock Option (right to buy) |
A - Award | 4 000 | 4 000 | |||||
2020-01-07 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
A - Award | 2 000 | 2 000 | |||||
2019-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Director Stock Option (right to buy) |
D - Sale to Issuer | −6 583 | 0 | −100,00 | ||||
2019-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Director Stock Option (right to buy) |
D - Sale to Issuer | −10 000 | 0 | −100,00 | ||||
2019-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Director Stock Option (right to buy) |
D - Sale to Issuer | −10 000 | 0 | −100,00 | ||||
2019-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Director Stock Option (right to buy) |
D - Sale to Issuer | −10 000 | 0 | −100,00 | ||||
2019-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Director Stock Option (right to buy) |
D - Sale to Issuer | −10 000 | 0 | −100,00 | ||||
2019-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
D - Sale to Issuer | −955 | 0 | −100,00 | ||||
2019-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
D - Sale to Issuer | −6 878 | 955 | −87,81 | ||||
2019-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 185 | 7 833 | 2,42 | 67,28 | 12 447 | 527 004 | |
2019-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 212 | 7 648 | 2,85 | 58,86 | 12 478 | 450 161 | |
2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Director Stock Option (right to buy) |
A - Award | 6 583 | 6 583 | |||||
2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 955 | 7 436 | 14,74 | ||||
2019-06-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 309 | 124 845 | 0,25 | 68,78 | 21 254 | 8 587 089 | |
2019-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 149 | 6 481 | 2,35 | 66,84 | 9 959 | 433 190 | |
2019-03-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −5 932 | 124 536 | −4,55 | 87,86 | −521 186 | 10 941 733 |
2019-03-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −5 836 | 130 468 | −4,28 | 88,05 | −513 860 | 11 487 707 | |
2019-03-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −9 597 | 136 304 | −6,58 | 94,09 | −902 982 | 12 824 843 |
2019-03-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
A - Award | 32 160 | 32 160 | |||||
2019-03-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 12 840 | 145 901 | 9,65 | ||||
2019-03-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −9 443 | 133 061 | −6,63 | 94,53 | −892 647 | 12 578 256 | |
2019-03-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 196 | 142 504 | −1,52 | 95,00 | −208 620 | 13 537 880 |
2019-03-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 154 | 144 700 | −0,79 | 94,76 | −109 353 | 13 711 772 | |
2019-03-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 15 687 | 145 854 | 12,05 | ||||
2019-02-26 |
|
4 | GHDX |
GENOMIC HEALTH INC
Director Stock Option (right to buy) |
M - Exercise | −3 521 | 0 | −100,00 | ||||
2019-02-26 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −521 | 6 332 | −7,60 | 79,80 | −41 577 | 505 302 | |
2019-02-26 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −3 000 | 6 853 | −30,45 | 78,88 | −236 650 | 540 587 | |
2019-02-26 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 3 521 | 9 853 | 55,61 | 27,75 | 97 708 | 273 421 | |
2019-02-26 |
|
4 | GHDX |
GENOMIC HEALTH INC
Director Stock Option (right to buy) |
M - Exercise | −6 479 | 3 521 | −64,79 | ||||
2019-02-26 |
|
4 | GHDX |
GENOMIC HEALTH INC
Director Stock Option (right to buy) |
M - Exercise | −20 000 | 0 | −100,00 | ||||
2019-02-26 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −510 | 6 332 | −7,45 | 82,25 | −41 945 | 520 778 | |
2019-02-26 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −14 490 | 6 842 | −67,93 | 81,70 | −1 183 887 | 559 017 | |
2019-02-26 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −11 479 | 21 332 | −34,99 | 82,11 | −942 572 | 1 751 628 | |
2019-02-26 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 6 479 | 32 811 | 24,61 | 27,75 | 179 792 | 910 505 | |
2019-02-26 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 20 000 | 26 332 | 315,86 | 33,67 | 673 400 | 886 598 | |
2019-01-22 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 11 000 | 11 000 | |||||
2019-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 155 | 6 332 | 2,51 | 64,41 | 9 984 | 407 844 | |
2018-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 142 | 6 177 | 2,35 | 70,18 | 9 966 | 433 502 | |
2018-08-28 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −12 500 | 130 167 | −8,76 | 100,00 | −1 250 000 | 13 016 700 | |
2018-08-28 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −12 500 | 142 667 | −8,06 | 99,00 | −1 237 500 | 14 124 033 | |
2018-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 198 | 6 035 | 3,39 | 50,40 | 9 979 | 304 164 | |
2018-06-18 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
M - Exercise | X | −20 681 | 0 | −100,00 | |||
2018-06-18 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
M - Exercise | X | −1 875 | 0 | −100,00 | |||
2018-06-18 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
M - Exercise | X | −2 669 | 0 | −100,00 | |||
2018-06-18 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
M - Exercise | X | −3 775 | 0 | −100,00 | |||
2018-06-18 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
M - Exercise | X | −2 000 | 0 | −100,00 | |||
2018-06-18 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −20 681 | 155 167 | −11,76 | 90,00 | −1 861 375 | 13 965 666 |
2018-06-18 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 20 681 | 175 848 | 13,33 | 37,46 | 774 710 | 6 587 266 |
2018-06-18 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −1 875 | 155 167 | −1,19 | 90,00 | −168 750 | 13 965 030 |
2018-06-18 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 1 875 | 157 042 | 1,21 | 26,49 | 49 669 | 4 160 043 |
2018-06-18 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 669 | 155 167 | −1,69 | 90,00 | −240 210 | 13 965 030 |
2018-06-18 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 2 669 | 157 836 | 1,72 | 37,46 | 99 981 | 5 912 537 |
2018-06-18 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −3 775 | 155 167 | −2,38 | 90,00 | −339 750 | 13 965 030 |
2018-06-18 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 3 775 | 158 942 | 2,43 | 26,49 | 100 000 | 4 210 374 |
2018-06-18 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 000 | 155 167 | −1,27 | 90,00 | −180 000 | 13 965 030 |
2018-06-18 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 2 000 | 157 167 | 1,29 | 21,51 | 43 020 | 3 380 662 |
2018-06-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Director Stock Option (right to buy) |
A - Award | 10 000 | 10 000 | |||||
2018-06-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 934 | 155 167 | −1,23 | 92,07 | −178 063 | 14 286 226 | |
2018-06-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 309 | 157 101 | 0,20 | 68,78 | 21 254 | 10 805 721 | |
2018-04-27 |
|
4/A | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −5 835 | 156 653 | −3,59 | 81,36 | −474 736 | 12 745 288 | |
2018-04-26 |
|
4/A | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 20 463 | 154 024 | 15,32 | ||||
2018-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 319 | 5 837 | 5,78 | 31,29 | 9 982 | 182 640 | |
2018-04-03 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
M - Exercise | X | −6 650 | 20 681 | −24,33 | |||
2018-04-03 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
M - Exercise | X | −3 350 | 1 875 | −64,11 | |||
2018-04-03 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −6 650 | 156 676 | −4,07 | 80,12 | −532 798 | 12 552 881 |
2018-04-03 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 6 650 | 163 326 | 4,24 | 37,46 | 249 109 | 6 118 192 |
2018-04-03 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −3 350 | 156 676 | −2,09 | 80,12 | −268 402 | 12 552 881 |
2018-04-03 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 3 350 | 160 026 | 2,14 | 26,49 | 88 742 | 4 239 089 |
2018-03-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −5 812 | 156 676 | −3,58 | 81,36 | −472 864 | 12 747 159 | |
2018-03-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
A - Award | 51 300 | 51 300 | |||||
2018-03-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 16 040 | 162 488 | 10,95 | ||||
2018-03-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −4 861 | 146 448 | −3,21 | 83,57 | −406 234 | 12 238 659 | |
2018-03-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −2 576 | 151 309 | −1,67 | 79,86 | −205 719 | 12 083 537 | |
2018-02-28 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 20 324 | 153 885 | 15,22 | ||||
2018-02-14 |
|
5 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
G - Gift | −415 | 133 561 | −0,31 | ||||
2018-01-22 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 10 000 | 10 000 | |||||
2018-01-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy Common Stock) |
M - Exercise | X | −10 000 | 27 331 | −26,79 | |||
2018-01-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy Common Stock) |
M - Exercise | X | −5 000 | 5 225 | −48,90 | |||
2018-01-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −15 000 | 133 976 | −10,07 | 89,23 | −1 338 400 | 11 954 236 |
2018-01-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 10 000 | 148 976 | 7,20 | 37,46 | 374 600 | 5 580 641 |
2018-01-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 5 000 | 138 976 | 3,73 | 26,49 | 132 450 | 3 681 474 |
2018-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 292 | 5 518 | 5,59 | 34,20 | 9 986 | 188 716 | |
2017-10-13 |
|
4/A | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
J - Other | 0 | 88 515 | 0,00 | ||||
2017-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 311 | 5 226 | 6,33 | 32,09 | 9 980 | 167 702 | |
2017-09-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −10 000 | 37 934 | −20,86 | |||
2017-09-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −5 000 | 10 225 | −32,84 | |||
2017-09-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −15 000 | 136 422 | −9,91 | 90,50 | −1 357 500 | 12 346 191 |
2017-09-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 10 000 | 151 422 | 7,07 | 37,46 | 374 600 | 5 672 268 |
2017-09-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 5 000 | 141 422 | 3,67 | 26,49 | 132 450 | 3 746 269 |
2017-07-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 307 | 4 915 | 6,66 | 32,55 | 9 993 | 159 983 | |
2017-06-20 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −603 | 47 331 | −1,26 | |||
2017-06-20 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −603 | 136 422 | −0,44 | 90,00 | −54 270 | 12 277 980 |
2017-06-20 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 603 | 137 025 | 0,44 | 37,46 | 22 588 | 5 132 956 |
2017-06-20 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −9 397 | 47 934 | −16,39 | |||
2017-06-20 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −5 000 | 15 225 | −24,72 | |||
2017-06-20 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −9 397 | 136 422 | −6,44 | 90,00 | −845 730 | 12 277 980 |
2017-06-20 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −5 000 | 145 819 | −3,32 | 90,00 | −450 000 | 13 123 710 |
2017-06-20 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 9 397 | 150 819 | 6,64 | 37,46 | 352 012 | 5 649 680 |
2017-06-20 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 5 000 | 141 422 | 3,67 | 26,49 | 132 450 | 3 746 269 |
2017-06-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Director Stock Option (right to buy) |
A - Award | 10 000 | 10 000 | |||||
2017-06-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −2 036 | 136 422 | −1,47 | 90,72 | −184 706 | 12 376 204 | |
2017-05-19 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 10 000 | 10 000 | |||||
2017-05-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −2 036 | 138 458 | −1,45 | 91,50 | −186 294 | 12 668 907 | |
2017-05-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 302 | 140 494 | 0,22 | 70,30 | 21 232 | 9 877 290 | |
2017-04-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 317 | 4 608 | 7,39 | 31,49 | 9 982 | 145 106 | |
2017-03-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
A - Award | 64 030 | 64 030 | |||||
2017-03-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 19 790 | 140 192 | 16,44 | ||||
2017-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −5 116 | 120 402 | −4,08 | 92,50 | −473 230 | 11 137 185 | |
2017-03-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −2 924 | 125 518 | −2,28 | 93,95 | −274 710 | 11 792 416 | |
2017-02-28 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
M - Exercise | X | −15 000 | 20 225 | −42,58 | |||
2017-02-28 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −15 000 | 128 442 | −10,46 | 87,99 | −1 319 850 | 11 301 612 |
2017-02-28 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 15 000 | 143 442 | 11,68 | 26,49 | 397 350 | 3 799 779 |
2017-02-28 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 14 564 | 128 442 | 12,79 | ||||
2017-01-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 340 | 4 291 | 8,61 | 29,39 | 9 993 | 126 112 | |
2016-11-29 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
M - Exercise | X | −15 000 | 35 225 | −29,87 | |||
2016-11-29 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −15 000 | 113 878 | −11,64 | 87,40 | −1 310 988 | 9 952 846 |
2016-11-29 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 15 000 | 128 878 | 13,17 | 26,49 | 397 350 | 3 413 978 |
2016-10-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 345 | 3 951 | 9,57 | 28,92 | 9 977 | 114 263 | |
2016-08-30 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock (Right to buy Common Stock) |
M - Exercise | X | −15 000 | 50 225 | −23,00 | |||
2016-08-30 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −15 000 | 113 878 | −11,64 | 95,06 | −1 425 924 | 10 825 425 |
2016-08-30 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 15 000 | 128 878 | 13,17 | 26,49 | 397 350 | 3 413 978 |
2016-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 373 | 3 606 | 11,54 | 26,74 | 9 974 | 96 424 | |
2016-06-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Director Stock Option (right to buy) |
A - Award | 10 000 | 10 000 | |||||
2016-06-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −2 036 | 113 878 | −1,76 | 90,00 | −183 240 | 10 249 020 | |
2016-05-31 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock (Right to buy Common Stock) |
M - Exercise | −15 000 | 65 225 | −18,70 | ||||
2016-05-31 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −5 000 | 115 914 | −4,14 | 87,34 | −436 700 | 10 123 929 | |
2016-05-31 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −10 000 | 120 914 | −7,64 | 88,04 | −880 400 | 10 645 269 | |
2016-05-31 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 15 000 | 130 914 | 12,94 | 26,49 | 397 350 | 3 467 912 | |
2016-05-19 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Option Grant (Right to Buy) |
A - Award | 10 000 | 10 000 | |||||
2016-05-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −2 036 | 115 914 | −1,73 | 82,71 | −168 398 | 9 587 247 | |
2016-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −3 131 | 117 950 | −2,59 | 80,80 | −252 985 | 9 530 360 | |
2016-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 415 | 121 081 | 0,34 | 51,26 | 21 275 | 6 207 096 | |
2016-04-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 392 | 3 233 | 13,80 | 25,48 | 9 988 | 82 377 | |
2016-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy) Common Stock |
A - Award | 44 340 | 44 340 | |||||
2016-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 19 790 | 120 666 | 19,62 | ||||
2016-03-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −3 043 | 100 876 | −2,93 | 89,57 | −272 562 | 9 035 463 | |
2016-03-02 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −56 464 | 103 919 | −35,21 | 81,87 | −4 622 708 | 8 507 849 | |
2016-02-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 7 437 | 160 383 | 4,86 | ||||
2016-02-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 59 520 | 152 946 | 63,71 | ||||
2016-02-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 20 580 | 93 426 | 28,25 | ||||
2016-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 284 | 2 841 | 11,11 | 35,20 | 9 997 | 100 003 | |
2015-10-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 468 | 2 557 | 22,40 | 21,34 | 9 987 | 54 566 | |
2015-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 365 | 2 089 | 21,17 | 27,34 | 9 979 | 57 113 | |
2015-06-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Director Stock Option (right to buy) |
A - Award | 10 000 | 10 000 | |||||
2015-06-08 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −1 864 | 72 846 | −2,49 | 122,32 | −228 001 | 8 910 384 |
2015-06-08 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −2 036 | 74 710 | −2,65 | 120,46 | −245 257 | 8 999 567 | |
2015-05-22 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Option Grant (Right to Buy) |
A - Award | 15 000 | 15 000 | |||||
2015-05-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −1 864 | 76 746 | −2,37 | 124,78 | −232 584 | 9 576 105 |
2015-05-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −2 036 | 78 610 | −2,52 | 122,78 | −249 980 | 9 651 736 | |
2015-05-14 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −1 434 | 80 646 | −1,75 | 121,37 | −174 038 | 9 787 626 |
2015-05-14 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 566 | 82 080 | −1,87 | 121,09 | −189 627 | 9 939 067 | |
2015-05-12 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 869 | 83 646 | −3,32 | 121,64 | −348 988 | 10 174 791 |
2015-05-12 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −3 131 | 86 515 | −3,49 | 121,66 | −380 917 | 10 525 415 | |
2015-05-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | 414 | 89 646 | 0,46 | 114,59 | 47 442 | 10 272 903 |
2015-05-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 1 425 | 90 060 | 1,61 | 51,26 | 73 050 | 4 616 791 | |
2015-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 328 | 1 724 | 23,50 | 30,43 | 9 981 | 52 461 | |
2015-03-18 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −5 845 | 2 000 | −74,51 | |||
2015-03-18 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −34 155 | 0 | −100,00 | |||
2015-03-18 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −41 315 | 88 635 | −31,79 | 123,57 | −5 105 166 | 10 952 352 |
2015-03-18 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 5 845 | 129 950 | 4,71 | 21,51 | 125 726 | 2 795 224 |
2015-03-18 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 34 155 | 124 105 | 37,97 | 21,51 | 734 674 | 2 669 499 |
2015-03-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
A - Award | 30 500 | 30 500 | |||||
2015-03-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 13 400 | 89 950 | 17,50 | ||||
2015-01-28 |
|
4/A | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −1 434 | 63 415 | −2,21 | 58,23 | −83 498 | 3 692 491 | |
2015-01-28 |
|
4/A | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −3 001 | 64 849 | −4,42 | 59,30 | −177 959 | 3 845 546 | |
2015-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 312 | 1 396 | 28,78 | 31,97 | 9 975 | 44 630 | |
2014-11-12 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | −20 000 | 34 155 | −36,93 | ||||
2014-11-12 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −20 000 | 76 550 | −20,71 | 86,55 | −1 730 982 | 6 625 334 | |
2014-11-12 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 20 000 | 96 550 | 26,13 | 21,51 | 430 200 | 2 076 790 | |
2014-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 350 | 1 084 | 47,68 | 28,54 | 9 989 | 30 937 | |
2014-09-11 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Option Grant (Right to Buy) |
A - Award | 15 000 | 15 000 | |||||
2014-09-11 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Option Grant (Right to Buy) |
A - Award | 15 000 | 15 000 | |||||
2014-09-11 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Option Grant (Right to Buy) |
A - Award | 16 000 | 16 000 | |||||
2014-08-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −10 000 | 54 155 | −15,59 | |||
2014-08-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −10 000 | 76 550 | −11,55 | 65,00 | −650 000 | 4 975 750 |
2014-08-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 10 000 | 86 550 | 13,06 | 21,51 | 215 100 | 1 861 690 |
2014-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 358 | 734 | 95,21 | 27,86 | 9 974 | 20 449 | |
2014-06-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Director Stock Option (right to buy) |
A - Award | 10 000 | 10 000 | |||||
2014-06-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock option (right to buy) common stock |
A - Award | 58 400 | 58 400 | |||||
2014-06-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 15 600 | 76 550 | 25,59 | ||||
2014-05-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −1 864 | 60 950 | −2,97 | 56,86 | −105 994 | 3 465 861 | |
2014-05-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −2 036 | 62 814 | −3,14 | 57,44 | −116 948 | 3 608 036 | |
2014-05-14 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −1 434 | 64 850 | −2,16 | 58,23 | −83 498 | 3 776 047 | |
2014-05-14 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 566 | 66 284 | −2,31 | 59,30 | −92 864 | 3 930 641 | |
2014-05-12 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −3 479 | 67 850 | −4,88 | 57,91 | −201 474 | 3 929 295 | |
2014-05-12 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −2 521 | 71 329 | −3,41 | 56,78 | −143 142 | 4 050 061 | |
2014-05-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −715 | 73 850 | −0,96 | 59,67 | −42 666 | 4 406 881 | |
2014-05-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 715 | 74 565 | 0,97 | 29,69 | 21 228 | 2 213 835 | |
2014-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 376 | 376 | 26,57 | 9 990 | 9 990 | ||
2014-02-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 31 500 | 73 850 | 74,38 | ||||
2014-02-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −10 000 | 64 155 | −13,49 | |||
2014-02-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −10 000 | 42 350 | −19,10 | 67,70 | −676 966 | 2 866 951 |
2014-02-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 10 000 | 52 350 | 23,61 | 21,51 | 215 100 | 1 126 048 |
2014-01-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −916 | 42 350 | −2,12 | 68,97 | −63 172 | 2 920 672 |
2013-09-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy Common Stock) |
D - Sale to Issuer | −10 000 | 0 | −100,00 | ||||
2013-09-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −10 000 | 43 266 | −18,77 | 80,19 | −801 900 | 3 469 501 |
2013-09-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 10 000 | 53 266 | 23,11 | 11,05 | 110 500 | 588 589 |
2013-09-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Director Stock Option (right to buy) |
A - Award | 20 000 | 20 000 | |||||
2013-09-09 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy Common Stock) |
D - Sale to Issuer | −10 000 | 10 000 | −50,00 | ||||
2013-09-09 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −10 000 | 43 266 | −18,77 | 70,00 | −700 000 | 3 028 620 |
2013-09-09 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 10 000 | 53 266 | 23,11 | 11,05 | 110 500 | 588 589 |
2013-07-02 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy Common Stock) |
D - Sale to Issuer | −10 000 | 20 000 | −33,33 | ||||
2013-07-02 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −10 000 | 43 266 | −18,77 | 60,00 | −600 000 | 2 595 960 |
2013-07-02 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 10 000 | 53 266 | 23,11 | 11,05 | 110 500 | 588 589 |
2013-06-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −1 098 | 43 266 | −2,47 | 58,32 | −64 036 | 2 523 295 |
2013-05-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −8 710 | 44 364 | −16,41 | 67,16 | −584 981 | 2 979 575 |
2013-05-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
D - Sale to Issuer | −10 000 | 30 000 | −25,00 | ||||
2013-05-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −11 899 | 53 074 | −18,31 | 65,66 | −781 240 | 3 484 621 |
2013-05-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 10 000 | 64 973 | 18,19 | 11,05 | 110 500 | 717 952 |
2013-05-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
A - Award | 91 000 | 91 000 | |||||
2013-05-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 15 600 | 54 973 | 39,62 | ||||
2013-05-14 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −3 001 | 39 373 | −7,08 | 67,68 | −203 108 | 2 664 765 | |
2013-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −3 131 | 42 374 | −6,88 | 65,32 | −204 517 | 2 767 870 | |
2013-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 916 | 45 505 | 2,05 | 22,20 | 20 340 | 1 010 439 | |
2013-05-01 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) |
M - Exercise | −20 000 | 40 000 | −33,33 | ||||
2013-05-01 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −20 000 | 44 589 | −30,97 | 63,29 | −1 265 800 | 2 822 038 | |
2013-05-01 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 20 000 | 64 589 | 44,85 | 11,05 | 221 000 | 713 708 | |
2013-03-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 908 | 44 589 | −4,10 | 59,61 | −113 736 | 2 657 950 | |
2013-02-13 |
|
5 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 101 | 46 497 | −2,31 | ||||
2013-02-13 |
|
5 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 101 | 46 497 | −2,31 | ||||
2012-11-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) |
M - Exercise | X | −10 000 | 286 000 | −3,38 | |||
2012-11-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −10 000 | 52 277 | −16,06 | 46,00 | −460 000 | 2 404 742 |
2012-11-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 10 000 | 62 277 | 19,13 | 11,05 | 110 500 | 688 161 |
2012-11-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) |
M - Exercise | X | −5 000 | 296 000 | −1,66 | |||
2012-11-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −5 000 | 52 277 | −8,73 | 37,08 | −185 384 | 1 938 264 |
2012-11-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 5 000 | 57 277 | 9,56 | 11,05 | 55 250 | 632 911 |
2012-10-03 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) |
M - Exercise | X | −5 000 | 301 000 | −1,63 | |||
2012-10-03 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −5 000 | 52 277 | −8,73 | 39,75 | −198 760 | 2 078 110 |
2012-10-03 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 5 000 | 57 277 | 9,56 | 11,05 | 55 250 | 632 911 |
2012-09-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) |
M - Exercise | X | −5 000 | 306 000 | −1,61 | |||
2012-09-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −5 000 | 52 277 | −8,73 | 37,76 | −188 790 | 1 973 880 |
2012-09-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 5 000 | 57 277 | 9,56 | 11,05 | 55 250 | 632 911 |
2012-08-02 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) |
M - Exercise | X | −5 000 | 311 000 | −1,58 | |||
2012-08-02 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −5 000 | 52 277 | −8,73 | 38,63 | −193 145 | 2 019 408 |
2012-08-02 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 5 000 | 57 277 | 9,56 | 11,05 | 55 250 | 632 911 |
2012-07-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) |
M - Exercise | −15 000 | 316 000 | −4,53 | ||||
2012-07-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −5 000 | 52 277 | −8,73 | 40,56 | −202 808 | 2 120 434 |
2012-07-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −10 000 | 57 277 | −14,86 | 40,00 | −400 000 | 2 291 080 |
2012-07-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 15 000 | 67 277 | 28,69 | 11,05 | 165 750 | 743 411 |
2012-06-20 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | −12 500 | 0 | −100,00 | 15,53 | −194 125 | ||
2012-06-20 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | −12 500 | 0 | −100,00 | 6,03 | −75 375 | ||
2012-06-20 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | −12 500 | 0 | −100,00 | 17,71 | −221 375 | ||
2012-06-20 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | −5 000 | 0 | −100,00 | 19,84 | −99 200 | ||
2012-06-20 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | −2 500 | 0 | −100,00 | 19,84 | −49 600 | ||
2012-06-20 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | −12 500 | 0 | −100,00 | 19,84 | −248 000 | ||
2012-06-20 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | −1 250 | 0 | −100,00 | 18,81 | −23 512 | ||
2012-06-20 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | −1 250 | 0 | −100,00 | 18,12 | −22 650 | ||
2012-06-20 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | −12 500 | 0 | −100,00 | 16,31 | −203 875 | ||
2012-06-20 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | −11 729 | 0 | −100,00 | 27,76 | −325 597 | ||
2012-06-20 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | −8 193 | 0 | −100,00 | 28,50 | −233 500 | ||
2012-06-20 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | −54 468 | 0 | −100,00 | 18,94 | −1 031 624 | ||
2012-06-20 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | −27 467 | 0 | −100,00 | 15,51 | −426 013 | ||
2012-06-20 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | −4 362 | 0 | −100,00 | 15,51 | −67 655 | ||
2012-06-20 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | −220 | 0 | −100,00 | 29,24 | −6 433 | ||
2012-06-20 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | −13 644 | 0 | −100,00 | 29,24 | −398 951 | ||
2012-06-20 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | −7 975 | 0 | −100,00 | 29,24 | −233 189 | ||
2012-06-20 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Common Stock |
D - Sale to Issuer | −10 416 | 0 | −100,00 | 32,00 | −333 312 | ||
2012-06-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) |
M - Exercise | −5 000 | 331 000 | −1,49 | ||||
2012-06-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −5 000 | 52 277 | −8,73 | 35,02 | −175 078 | 1 830 505 |
2012-06-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 5 000 | 57 277 | 9,56 | 11,05 | 55 250 | 632 911 |
2012-05-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −1 741 | 52 277 | −3,22 | 38,64 | −67 279 | 2 020 187 | |
2012-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) |
A - Award | 60 000 | 336 000 | 21,74 | ||||
2012-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 24 000 | 54 018 | 79,95 | ||||
2012-05-03 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy |
M - Exercise | X | −5 000 | 276 000 | −1,78 | |||
2012-05-03 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −5 000 | 30 018 | −14,28 | 34,99 | −174 950 | 1 050 330 |
2012-05-03 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 5 000 | 35 018 | 16,66 | 11,05 | 55 250 | 386 949 |
2012-05-03 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 1 098 | 30 018 | 3,80 | 19,35 | 21 242 | 580 728 | |
2012-04-26 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Stock Option (Right to Buy) |
M - Exercise | X | −10 000 | 7 975 | −55,63 | |||
2012-04-26 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Common Stock |
S - Sale | X | −10 000 | 10 416 | −48,98 | 31,64 | −316 432 | 329 596 |
2012-04-26 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Common Stock |
M - Exercise | X | 10 000 | 20 416 | 96,01 | 2,76 | 27 600 | 56 348 |
2012-04-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −7 691 | 28 920 | −21,01 | 35,00 | −269 185 | 1 012 200 |
2012-04-03 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) |
M - Exercise | −5 000 | 281 000 | −1,75 | ||||
2012-04-03 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −5 000 | 36 611 | −12,02 | 34,08 | −170 380 | 1 247 556 |
2012-04-03 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 5 000 | 41 611 | 13,66 | 11,05 | 55 250 | 459 802 |
2012-01-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) |
M - Exercise | −2 500 | 286 000 | −0,87 | ||||
2012-01-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 500 | 36 611 | −6,39 | 34,75 | −86 883 | 1 272 349 |
2012-01-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 2 500 | 39 111 | 6,83 | 11,05 | 27 625 | 432 177 |
2012-01-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 156 | 36 611 | 0,43 | 13,23 | 2 063 | 484 217 | |
2012-01-05 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Stock Option (Right to Buy) |
A - Award | 12 500 | 12 500 | |||||
2010-07-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) |
M - Exercise | X | 833 | 233 667 | 0,36 | |||
2010-07-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −833 | 31 000 | −2,62 | 20,00 | −16 660 | 620 000 |
2010-07-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 833 | 31 833 | 2,69 | 11,05 | 9 205 | 351 755 |